MedMira Inc. (TSXV: MIR)
Canada flag Canada · Delayed Price · Currency is CAD
0.0800
0.00 (0.00%)
Nov 19, 2024, 3:05 PM EST

MedMira Company Description

MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, the Asia Pacific, and internationally.

The company offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product to perform preliminary screening of HIV and hepatitis.

It also provides Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests.

In addition, the company offers VYRATM TriDemic antigen rapid test that distinguishes the three respiratory viruses, such as SARS-CoV-2, influenza, and respiratory syncytial virus that exhibit similar symptoms.

It sells its products through a network of medical distributors and strategic business development partners to customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care clinics, governments, aid organizations, and public health agencies.

The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.

MedMira Inc.
MedMira logo
Country Canada
Founded 1993
Industry Biotechnology
Sector Healthcare
Employees 52
CEO Hermes Chan

Contact Details

Address:
155 Chain Lake Drive
Halifax, Alberta B3S 1B3
Canada
Phone 902 450 1588
Website medmira.com

Stock Details

Ticker Symbol MIR
Exchange TSX Venture Exchange
Fiscal Year August - July
Reporting Currency CAD
ISIN Number CA58501R1029
SIC Code 2835

Key Executives

Name Position
Hermes Chan Co-Founder, Chief Executive Officer, President and Director
Markus M. Meile Chief Financial Officer
Dr. Sam Ratnam Director of Scientific and Regulatory Affairs
Stewart McKelvey Legal Counsel
Dr. Kevin D. Jones Head of Commercialization and Senior Director of Sales and Marketing